[HTML][HTML] Dyspnea in COPD: new mechanistic insights and management implications

DE O'Donnell, KM Milne, MD James, JP de Torres… - Advances in …, 2020 - Springer
Dyspnea is the most common symptom experienced by patients with chronic obstructive
pulmonary disease (COPD). To avoid exertional dyspnea, many patients adopt a sedentary …

Palliative care for people living with heart failure: European Association for Palliative Care Task Force expert position statement

PZ Sobanski, B Alt-Epping, DC Currow… - Cardiovascular …, 2020 - academic.oup.com
Contrary to common perception, modern palliative care (PC) is applicable to all people with
an incurable disease, not only cancer. PC is appropriate at every stage of disease …

Managing the supportive care needs of those affected by COVID-19

S Bajwah, A Wilcock, R Towers… - European …, 2020 - Eur Respiratory Soc
Globally, the number of people affected by coronavirus disease 2019 (COVID-19) is rapidly
increasing. In most (> 80%), the illness is relatively mild and can be self-managed out of …

[HTML][HTML] Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease

SG Kapnadak, E Dimango, D Hadjiliadis… - Journal of Cystic …, 2020 - Elsevier
Background Advanced cystic fibrosis lung disease (ACFLD) is common, is associated with
reduced quality of life, and remains the most frequent cause of death in individuals with …

Towards an expert consensus to delineate a clinical syndrome of chronic breathlessness

MJ Johnson, J Yorke… - European …, 2017 - Eur Respiratory Soc
Breathlessness that persists despite treatment for the underlying conditions is debilitating.
Identifying this discrete entity as a clinical syndrome should raise awareness amongst …

COVID-19: guidance on palliative care from a European Respiratory Society international task force

DJA Janssen, M Ekström, DC Currow… - European respiratory …, 2020 - Eur Respiratory Soc
Background Many people are dying from coronavirus disease 2019 (COVID-19), but
consensus guidance on palliative care in COVID-19 is lacking. This new life-threatening …

Effect of sustained-release morphine for refractory breathlessness in chronic obstructive pulmonary disease on health status: a randomized clinical trial

CA Verberkt, MHJ van den Beuken-van… - JAMA Internal …, 2020 - jamanetwork.com
Importance Morphine is used as palliative treatment of chronic breathlessness in patients
with advanced chronic obstructive pulmonary disease (COPD). Evidence on respiratory …

[HTML][HTML] COVID-19: Pain management in patients with SARS-CoV-2 infection—molecular mechanisms, challenges, and perspectives

S Drożdżal, J Rosik, K Lechowicz, F Machaj, B Szostak… - Brain Sciences, 2020 - mdpi.com
Since the end of 2019, the whole world has been struggling with the pandemic of the new
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2). Available evidence …

[HTML][HTML] Leitlinie zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem (COPD)

C Vogelmeier, R Buhl, O Burghuber, CP Criée… - …, 2018 - thieme-connect.com
Das vorliegende Dokument ist eine Neufassung und Aktualisierung der Leitlinie zur
Diagnostik und Therapie von Patienten mit COPD, die die bisherige Version aus dem Jahr …

Effect of regular, low-dose, extended-release morphine on chronic breathlessness in chronic obstructive pulmonary disease: the BEAMS randomized clinical trial

M Ekström, D Ferreira, S Chang, S Louw, MJ Johnson… - Jama, 2022 - jamanetwork.com
Importance Chronic breathlessness is common in people with chronic obstructive pulmonary
disease (COPD). Regular, low-dose, extended-release morphine may relieve …